Derek Hicks is the Executive Vice President, Chief Business Officer for Intellia, a leading clinical-stage genome editing company, developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Hicks brings more than 25 years of combined business leadership and biotechnology experience to Intellia.
As Chief Business Officer at Intellia, Derek is responsible for overall corporate strategy, portfolio planning and developing new business and strategic partnerships.
Prior to Intellia, Hicks served as Head of Business Development at Spark Therapeutics. While at Spark, he was responsible for business development strategy, search and evaluation, licensing, and key partnership activities.
Prior to this role, Hicks spent 18 years at Pfizer in a variety of business and corporate development roles culminating with his position as Vice President, Corporate Development, World-Wide Business Development.
Hicks holds his Bachelor of Science and Masters of Science in Mechanical Engineering from the University of Connecticut and MBA from Indiana University, Kelley School of Business.
